IgG4-related disease and Rosai-Dorfman-Destombes disease - Authors' reply
- PMID: 34600621
- DOI: 10.1016/S0140-6736(21)01811-0
IgG4-related disease and Rosai-Dorfman-Destombes disease - Authors' reply
Conflict of interest statement
FC-A and JH are investigators (FC-A being the principal investigator) of an academic study on the efficacy of cobimetinib for treating histiocytoses (COBRAH, NCT 04007848). All other authors declare no competing interests.
Comment on
-
IgG4-related disease and Rosai-Dorfman-Destombes disease.Lancet. 2021 Oct 2;398(10307):1213-1214. doi: 10.1016/S0140-6736(21)01812-2. Lancet. 2021. PMID: 34600619 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
